Australia Cell Culture Market Size & Outlook, 2023-2030
Australia cell culture market, 2018-2030 (US$M)
Related Markets
Australia cell culture market highlights
- The Australia cell culture market generated a revenue of USD 314.3 million in 2023 and is expected to reach USD 768.2 million by 2030.
- The Australia market is expected to grow at a CAGR of 13.6% from 2024 to 2030.
- In terms of segment, consumables was the largest revenue generating product in 2023.
- Consumables is the most lucrative product segment registering the fastest growth during the forecast period.
Cell culture market data book summary
| Market revenue in 2023 | USD 314.3 million |
| Market revenue in 2030 | USD 768.2 million |
| Growth rate | 13.6% (CAGR from 2023 to 2030) |
| Largest segment | Consumables |
| Fastest growing segment | Consumables |
| Historical data | 2018 - 2022 |
| Base year | 2023 |
| Forecast period | 2024 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Consumables, Instruments |
| Key market players worldwide | Sartorius AG, Danaher Corp, Merck KGaA, Thermo Fisher Scientific Inc, Corning Inc, Avantor Inc, BD, Eppendorf, Bio-Techne Corp, PromoCell GmbH |
Other key industry trends
- In terms of revenue, Australia accounted for 1.7% of the global cell culture market in 2023.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
- In Asia Pacific, China cell culture market is projected to lead the regional market in terms of revenue in 2030.
- China is the fastest growing regional market in Asia Pacific and is projected to reach USD 2,766.0 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Cell Culture Market Scope
Cell Culture Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
Australia cell culture market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to cell culture market will help companies and investors design strategic landscapes.
Consumables was the largest segment with a revenue share of 57.17% in 2023. Horizon Databook has segmented the Australia cell culture market based on consumables, instruments covering the revenue growth of each sub-segment from 2018 to 2030.
The availability of advanced research facilities, highly qualified researchers, and a firm but flexible regulatory framework made Australia a powerhouse of pharmaceutical & biotechnology innovation. As per the Australian Trade and Investment Commission, Australia is home to more than 470 biotechnology companies.
The presence of established biotechnology & pharmaceutical players and the significant extent of R&D activities carried out by them are expected to create high demand for cell culture solutions & systems in the country. Furthermore, market players are increasingly adopting inorganic growth strategies to enter the Australian market, which is anticipated to support market growth in the country.
For instance, in February 2023, Inventia Life Science, an Australia-based startup, collaborated with Merck & Co. to use its RASTRUM 3D cell culture platform to develop 3D in vitro models for studying neurodegenerative disease therapeutic candidates. Such initiatives are expected to positively affect the market growth over the forecast period. Key players in the country include Thermo Fisher Scientific, Danaher, BD, Eppendorf & others.
Reasons to subscribe to Australia cell culture market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Australia cell culture market databook
-
Our clientele includes a mix of cell culture market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the Australia cell culture market , including forecasts for subscribers. This country databook contains high-level insights into Australia cell culture market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
Australia cell culture market size, by product, 2018-2030 (US$M)
Australia Cell Culture Market Outlook Share, 2023 & 2030 (US$M)
Related industry reports
Related regional statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
